| APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
| BDNF |
P23560
|
brain derived neurotrophic factor
|
Signaling
|
0.66 |
0.345 |
0.923 |
| C20orf181 |
|
chromosome 20 open reading frame 181
|
|
|
0.479 |
0.885 |
| COMT |
P21964
|
catechol-O-methyltransferase
|
Enzyme
|
1.1E-06 |
0.400 |
0.923 |
| CREM |
Q03060
|
cAMP responsive element modulator
|
|
0.51 |
0.575 |
0.692 |
| CYP2C19 |
P33261
|
cytochrome P450 family 2 subfamily C member 19
|
|
6.5E-20 |
0.467 |
0.846 |
| DRD2 |
P14416
|
dopamine receptor D2
|
G-protein coupled receptor
|
0.75 |
0.436 |
0.846 |
| DRD4 |
P21917
|
dopamine receptor D4
|
G-protein coupled receptor
|
9.3E-09 |
0.517 |
0.577 |
| GABRB3 |
P28472
|
gamma-aminobutyric acid type A receptor subunit beta3
|
Ion channel
|
0.95 |
0.546 |
0.615 |
| GRM2 |
Q14416
|
glutamate metabotropic receptor 2
|
G-protein coupled receptor
|
0.12 |
0.582 |
0.577 |
| HTR2C |
P28335
|
5-hydroxytryptamine receptor 2C
|
G-protein coupled receptor
|
3.7E-02 |
0.555 |
0.692 |
| KRT7 |
P08729
|
keratin 7
|
|
3.1E-12 |
0.463 |
0.808 |
| MAOA |
P21397
|
monoamine oxidase A
|
|
1.00 |
0.465 |
0.769 |
| NPS |
P0C0P6
|
neuropeptide S
|
|
1.4E-04 |
0.619 |
0.615 |
| NPY |
P01303
|
neuropeptide Y
|
Signaling
|
0.14 |
0.447 |
0.846 |
| OPRK1 |
P41145
|
opioid receptor kappa 1
|
G-protein coupled receptor
|
4.1E-05 |
0.555 |
0.615 |
| OXTR |
P30559
|
oxytocin receptor
|
G-protein coupled receptor
|
7.1E-04 |
0.541 |
0.769 |
| PON1 |
P27169
|
paraoxonase 1
|
|
9.8E-11 |
0.409 |
0.885 |
| SCLY |
Q96I15
|
selenocysteine lyase
|
Enzyme
|
2.3E-09 |
0.530 |
0.731 |
| SLC6A3 |
Q01959
|
solute carrier family 6 member 3
|
Transporter
|
1.00 |
0.453 |
0.885 |
| SLC6A4 |
P31645
|
solute carrier family 6 member 4
|
Transporter
|
0.25 |
0.429 |
0.808 |
| TAL1 |
P17542
|
TAL bHLH transcription factor 1, erythroid differentiation factor
|
Transcription factor
|
0.57 |
0.505 |
0.731 |
| WASF1 |
Q92558
|
WASP family member 1
|
Cellular structure
|
1.00 |
0.547 |
0.808 |